ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparison of the Efficacy and Safety of Risperidone Versus Risperidone Plus Low Dose of Haloperidol in the Treatment of Schizophrenia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00998608
Recruitment Status : Terminated (terminated)
First Posted : October 20, 2009
Last Update Posted : October 20, 2009
Sponsor:
Information provided by:
Kaohsiung Kai-Suan Psychiatric Hospital